Total submissions: 20
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000078657 | SCV000110513 | benign | not specified | 2013-07-05 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV000078657 | SCV000152633 | benign | not specified | 2016-05-04 | criteria provided, single submitter | clinical testing | |
Genomic Diagnostic Laboratory, |
RCV000078657 | SCV000257669 | benign | not specified | 2015-06-16 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000078657 | SCV000303637 | likely benign | not specified | criteria provided, single submitter | clinical testing | ||
Illumina Laboratory Services, |
RCV000392057 | SCV000405221 | likely benign | Hypokalemic periodic paralysis, type 2 | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. |
Illumina Laboratory Services, |
RCV000309597 | SCV000405222 | likely benign | Congenital myasthenic syndrome 16 | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. |
Illumina Laboratory Services, |
RCV000368999 | SCV000405223 | likely benign | Potassium-aggravated myotonia | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. |
Illumina Laboratory Services, |
RCV000020268 | SCV000405224 | likely benign | Hyperkalemic periodic paralysis | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. |
Illumina Laboratory Services, |
RCV000315013 | SCV000405225 | likely benign | Paramyotonia congenita of Von Eulenburg | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. |
Gene |
RCV000078657 | SCV000520903 | benign | not specified | 2016-02-18 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Center for Pediatric Genomic Medicine, |
RCV000514862 | SCV000610280 | likely benign | not provided | 2017-07-05 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000020268 | SCV000658532 | benign | Hyperkalemic periodic paralysis | 2025-02-03 | criteria provided, single submitter | clinical testing | |
Broad Center for Mendelian Genomics, |
RCV001258245 | SCV001435159 | likely benign | Joubert syndrome 17 | criteria provided, single submitter | research | The heterozygous p.Val781Ile variant in SCN4A has been identified in 2 individuals with hyperkalaemic periodic paralysis (PMID: 7695243, 18046642), and has been identified in >2% of Latino chromosomes and 9 homozygotes by ExAC (http://gnomad.broadinstitute.org/). In vitro functional studies provide some evidence that the p.Val781Ile variant may not impact protein function (PMID: 9266738). However, these types of assays may not accurately represent biological function. In summary, although additional studies are required to fully establish its clinical significance, this variant meets criteria to be classified as likely benign for hyperkalaemic periodic paralysis. | |
Fulgent Genetics, |
RCV002496423 | SCV002802129 | likely benign | Hypokalemic periodic paralysis, type 1; Potassium-aggravated myotonia; Paramyotonia congenita of Von Eulenburg; Hypokalemic periodic paralysis, type 2; Hyperkalemic periodic paralysis; Congenital myasthenic syndrome 16 | 2022-04-16 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000514862 | SCV004138796 | benign | not provided | 2025-03-01 | criteria provided, single submitter | clinical testing | SCN4A: BS1, BS2 |
Breakthrough Genomics, |
RCV000514862 | SCV005211234 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Gene |
RCV000020268 | SCV000040622 | not provided | Hyperkalemic periodic paralysis | no assertion provided | literature only | ||
Diagnostic Laboratory, |
RCV000078657 | SCV001742129 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000514862 | SCV001932524 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Laboratory of Diagnostic Genome Analysis, |
RCV000514862 | SCV002035576 | likely benign | not provided | no assertion criteria provided | clinical testing |